Recessive inborn errors of type I IFN immunity in children with COVID-19 pneumonia
360
Adult
0301 basic medicine
Science::Medicine
SARS-CoV-2
SARS-Cov-2
Immunology
Brief Definitive Report
Inheritance Patterns
610
COVID-19
Pneumonia
Settore MED/03 - GENETICA MEDICA
618
Simplex-Virus Encephalitis
03 medical and health sciences
Pyogenic Bacterial-Infections
Interferon Type I
Medicine and Health Sciences
Immunology and Allergy
Humans
:Medicine [Science]
Child
DOI:
10.1084/jem.20220131
Publication Date:
2022-06-16T13:59:26Z
AUTHORS (174)
ABSTRACT
Recessive or dominant inborn errors of type I interferon (IFN) immunity can underlie critical COVID-19 pneumonia in unvaccinated adults. The risk children, which is much lower than adults, remains unexplained. In an international cohort 112 children (<16 yr old) hospitalized for pneumonia, we report 12 (10.7%) aged 1.5–13 with (7 children), severe (3), and moderate (2) 4 the 15 known clinically recessive biochemically complete IFN immunity: X-linked TLR7 deficiency children) autosomal IFNAR1 (1), STAT2 TYK2 (3) deficiencies. Fibroblasts deficient IFNAR1, STAT2, are highly vulnerable to SARS-CoV-2. These deficiencies were not found 1,224 adults benign SARS-CoV-2 infection without (P = 1.2 × 10−11) overlapping age, sex, consanguinity, ethnicity characteristics. may ∼10% hospitalizations children.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (96)
CITATIONS (83)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....